NSE BSE
aurobindo pharma ltd stock

AUROBINDO PHARMA LTD Share Price

- - (%)
Sector: -

275

524804

AUROPHARMA

img img img img
No Data Available

AUROBINDO PHARMA LTD Share Price Update


As of the latest trading session, AUROBINDO PHARMA LTD share price is currently at 1202.4, which is up by 37.34 from its previous closing. Today, the stock has fluctuated between 1165.05 and 1212.00. Over the past year, AUROBINDO PHARMA LTD has achieved a return of 88.03 %. In the last month alone, the return has been 4.53 %.

AUROBINDO PHARMA LTD Performance

Day Range

Low1165.05 High1212.00
1202.40

52 Week Range

Low 581.25 High 1212.00
1202.40

Open Price

1165.05

Prev. Close

1165.05

Volume (Shares)

415670.00

Total traded value

4998.01

Upper Circuit

1223.30

Lower Circuit

1106.80

Note: The current prices & values are delayed, Login to your account for live updates.

AUROBINDO PHARMA LTD Fundamentals


(Standalone)

Market Cap (Cr) 70453.27
PE Ratio (TTM) 34.88
Book Value / Share 318.54
Beta 0.55
ROE 7.02%
EPS (TTM) 33.56
Dividend Yield 0.62%
Net Profit Qtr (Cr) 623.78

AUROBINDO PHARMA LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 2663.87
Operating Expense 2335.94
Net Profit 623.78
Net Profit Margin (%) 23.41
Earnings Per Share (EPS) 10.65
EBITDA 812.82
Effective Tax Rate (%) 9.23
Particulars SEP 2023 (Values in Cr)
Revenue 2648.41
Operating Expense 2226.06
Net Profit 415.74
Net Profit Margin (%) 15.69
Earnings Per Share (EPS) 7.10
EBITDA 612.26
Effective Tax Rate (%) 25.52
Particulars JUN 2023 (Values in Cr)
Revenue 2363.53
Operating Expense 2059.66
Net Profit 335.95
Net Profit Margin (%) 14.21
Earnings Per Share (EPS) 5.74
EBITDA 517.26
Effective Tax Rate (%) 25.35
Particulars MAR 2023 (Values in Cr)
Revenue 2371.73
Operating Expense 1928.74
Net Profit 644.80
Net Profit Margin (%) 27.18
Earnings Per Share (EPS) 10.22
EBITDA 855.90
Effective Tax Rate (%) 14.87
Particulars DEC 2022 (Values in Cr)
Revenue 2336.52
Operating Expense 2001.81
Net Profit 298.82
Net Profit Margin (%) 12.78
Earnings Per Share (EPS) 5.10
EBITDA 522.24
Effective Tax Rate (%) 26.11
Particulars MAR 2023 (Values in Cr)
Revenue 8371.54
Operating Expense 7265.84
Net Profit 1230.41
Net Profit Margin (%) 14.69
Earnings Per Share (EPS) 21.00
EBITDA 1951.93
Effective Tax Rate (%) 23.78
Particulars MAR 2022 (Values in Cr)
Revenue 11250.07
Operating Expense 10245.94
Net Profit 1454.71
Net Profit Margin (%) 12.93
Earnings Per Share (EPS) 24.83
EBITDA 2069.68
Effective Tax Rate (%) 11.16
Particulars MAR 2021 (Values in Cr)
Revenue 15622.18
Operating Expense 12220.53
Net Profit 3112.91
Net Profit Margin (%) 19.92
Earnings Per Share (EPS) 53.13
EBITDA 4709.69
Effective Tax Rate (%) 25.75
Particulars MAR 2020 (Values in Cr)
Revenue 13038.82
Operating Expense 11244.15
Net Profit 1876.88
Net Profit Margin (%) 14.39
Earnings Per Share (EPS) 32.03
EBITDA 2941.29
Effective Tax Rate (%) 20.80
Particulars MAR 2019 (Values in Cr)
Revenue 11938.70
Operating Expense 10402.87
Net Profit 1529.73
Net Profit Margin (%) 12.81
Earnings Per Share (EPS) 26.11
EBITDA 2508.56
Effective Tax Rate (%) 22.13
Particulars MAR 2023 (Values in Cr)
Book Value / Share 458.10
ROE % 7.50
ROCE % 9.18
Total Debt to Total Equity 0.16
EBITDA Margin 16.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share 419.46
ROE % 11.38
ROCE % 12.41
Total Debt to Total Equity 0.18
EBITDA Margin 19.39
Particulars MAR 2021 (Values in Cr)
Book Value / Share 374.29
ROE % 17.59
ROCE % 18.29
Total Debt to Total Equity 0.29
EBITDA Margin 22.84
Particulars MAR 2020 (Values in Cr)
Book Value / Share 287.16
ROE % 18.52
ROCE % 18.51
Total Debt to Total Equity 0.42
EBITDA Margin 21.71
Particulars MAR 2019 (Values in Cr)
Book Value / Share 237.08
ROE % 18.49
ROCE % 17.91
Total Debt to Total Equity 0.46
EBITDA Margin 20.56
Particulars MAR 2023 (Values in Cr)
Book Value / Share 305.75
ROE % 7.02
ROCE % 8.39
Total Debt to Total Equity 0.17
EBITDA Margin 16.92
Particulars MAR 2022 (Values in Cr)
Book Value / Share 292.15
ROE % 8.81
ROCE % 8.49
Total Debt to Total Equity 0.18
EBITDA Margin 18.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share 271.80
ROE % 21.49
ROCE % 22.94
Total Debt to Total Equity 0.27
EBITDA Margin 29.76
Particulars MAR 2020 (Values in Cr)
Book Value / Share 222.78
ROE % 15.38
ROCE % 15.97
Total Debt to Total Equity 0.34
EBITDA Margin 23.09
Particulars MAR 2019 (Values in Cr)
Book Value / Share 193.73
ROE % 14.34
ROCE % 14.82
Total Debt to Total Equity 0.39
EBITDA Margin 21.28
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6084.20
Total Assets 39889.99
Total Liabilities 39889.99
Total Equity 26851.85
Share Outstanding 585938609
Price to Book Ratio 1.69
Return on Assets (%) 4.83
Return on Capital (%) 6.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4190.01
Total Assets 33921.72
Total Liabilities 33921.72
Total Equity 24574.05
Share Outstanding 585938609
Price to Book Ratio 2.29
Return on Assets (%) 7.80
Return on Capital (%) 9.83
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5474.28
Total Assets 33853.99
Total Liabilities 33853.99
Total Equity 21928.99
Share Outstanding 585915609
Price to Book Ratio 3.24
Return on Assets (%) 15.75
Return on Capital (%) 19.83
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 2842.15
Total Assets 28927.74
Total Liabilities 28927.74
Total Equity 16824.81
Share Outstanding 585915609
Price to Book Ratio 1.85
Return on Assets (%) 9.83
Return on Capital (%) 12.79
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 1957.18
Total Assets 26454.36
Total Liabilities 26454.36
Total Equity 13892.37
Share Outstanding 585915609
Price to Book Ratio 4.06
Return on Assets (%) 8.93
Return on Capital (%) 11.45
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 132.14
Total Assets 24933.65
Total Liabilities 24933.65
Total Equity 17914.17
Share Outstanding 585938609
Price to Book Ratio 1.69
Return on Assets (%) 4.93
Return on Capital (%) 5.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 50.78
Total Assets 21600.95
Total Liabilities 21600.95
Total Equity 17117.34
Share Outstanding 585938609
Price to Book Ratio 2.29
Return on Assets (%) 6.73
Return on Capital (%) 7.68
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 386.18
Total Assets 23188.99
Total Liabilities 23188.99
Total Equity 15924.61
Share Outstanding 585915609
Price to Book Ratio 3.24
Return on Assets (%) 13.42
Return on Capital (%) 15.66
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 86.16
Total Assets 19563.61
Total Liabilities 19563.61
Total Equity 13052.50
Share Outstanding 585915609
Price to Book Ratio 1.85
Return on Assets (%) 9.59
Return on Capital (%) 11.18
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 75.77
Total Assets 18140.72
Total Liabilities 18140.72
Total Equity 11350.62
Share Outstanding 585915609
Price to Book Ratio 4.06
Return on Assets (%) 8.43
Return on Capital (%) 9.64
Particulars MAR 2023 (Values in Cr)
Net Income 2612.50
Cash from Operations 3103.99
Cash from Investing -3977.75
Cash from Financing 1814.41
Net change in Cash 223.41
Free Cash Flow 5507.79
Particulars MAR 2022 (Values in Cr)
Net Income 3372.74
Cash from Operations 6274.67
Cash from Investing -3211.56
Cash from Financing -2969.27
Net change in Cash -1164.35
Free Cash Flow 8327.58
Particulars MAR 2021 (Values in Cr)
Net Income 7343.59
Cash from Operations 4614.30
Cash from Investing 598.69
Cash from Financing -1364.94
Net change in Cash 2562.80
Free Cash Flow 6052.24
Particulars MAR 2020 (Values in Cr)
Net Income 3743.04
Cash from Operations 5142.12
Cash from Investing -1567.64
Cash from Financing -1947.18
Net change in Cash 866.46
Free Cash Flow 6524.87
Particulars MAR 2019 (Values in Cr)
Net Income 3091.35
Cash from Operations 2420.80
Cash from Investing -2902.59
Cash from Financing 1919.06
Net change in Cash 667.44
Free Cash Flow 3846.48
Particulars MAR 2023 (Values in Cr)
Net Income 1614.35
Cash from Operations 2121.75
Cash from Investing -3459.68
Cash from Financing 1719.48
Net change in Cash 80.96
Free Cash Flow 2475.50
Particulars MAR 2022 (Values in Cr)
Net Income 1637.48
Cash from Operations 4418.78
Cash from Investing -1613.51
Cash from Financing -2447.54
Net change in Cash -334.34
Free Cash Flow 5032.84
Particulars MAR 2021 (Values in Cr)
Net Income 4193.01
Cash from Operations 3621.38
Cash from Investing -2648.73
Cash from Financing -28.06
Net change in Cash 317.74
Free Cash Flow 4018.11
Particulars MAR 2020 (Values in Cr)
Net Income 2370.05
Cash from Operations 2580.07
Cash from Investing -951.68
Cash from Financing -1254.65
Net change in Cash -4.95
Free Cash Flow 3261.69
Particulars MAR 2019 (Values in Cr)
Net Income 1964.62
Cash from Operations 1012.01
Cash from Investing -1297.36
Cash from Financing 599.40
Net change in Cash -168.07
Free Cash Flow 1902.07
Company Name Price P/E P/B Market Cap 52 Week Low/High
AUROBINDO PHARMA LTD 1202.65 25.07 2.49 70467.91 581.50 / 1211.65
BLISS GVS PHARMA LTD 110.40 12.07 1.19 1155.79 71.00 / 148.95
CIPLA LTD 1403.90 26.62 4.24 113350.18 913.20 / 1519.00
FERMENTA BIOTECH LIMITED 162.85 0.00 1.67 479.28 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2355.75 57.70 22.44 39907.83 1275.05 / 2649.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AUROBINDO PHARMA LTD 1202.65 35.84 3.77 70467.91 581.50 / 1211.65
AMRUTAJAN HEALTH LTD 743.15 48.83 8.20 2148.49 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.35 90.24 21.97 14393.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 110.40 15.25 1.16 1155.79 71.00 / 148.95
ABBOTT INDIA LIMITED 26643.70 47.13 15.30 56617.86 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1159.10
  • 26 Days 1137.40
  • 10 Days 1155.00
  • 50 Days 1105.60
  • 12 Days 1154.40
  • 100 Days 1088.60
  • 20 Days 1141.50
  • 200 Days 828.40
1169.42
PIVOT
First Resistance 1181.28
Second Resistance 1197.52
Third Resistance 1209.38
First Support 1153.18
Second Support 1141.32
Third Support 1125.08
RSI 58.40
MACD 17.03
Commodity Channel Index (CCI) 93.89
ADX 14.40
Williams % R -27.01

Over 1 Month

down

4.53

Over 3 Months

down

11.92

Over 6 Months

down

15.65

Over 1 Year

down

88.03

Over 3 Years

down

5.14

Over 5 Years

down

11.68

AUROBINDO PHARMA LTD Future

Future: Price

30 May
1164.00
27 Jun
1172.45
25 Jul
1174.25
25 May
0 100 200 300 400 500 600

Discount/Premium

30 May
5.60
27 Jun
14.05
25 Jul
15.85
25 May
0 1 2 3 4 5 6 7

Active Calls

1200.0
2249
1180.0
1778
1160.0
1711
25 May
0 500 1000 1500 2000 2500 3000

Active Puts

1160.0
1007
1100.0
787
1080.0
633
25 Jul
0 500 1000 1500 2000 2500

AUROBINDO PHARMA LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
12.32
Promoter Holdings
51.83
FII
18.01
DII
17.82
Promoter Shares(Pledge Percentage)
20.86
Name Category Shares Shares%
Rpr Sons Advisors Private Limited, Mrs.p.suneela Rani (jointly Holding) Shareholding of Promoter and Promoter Group 1.9637625E8 33.51
K Nityananda Reddy Shareholding of Promoter and Promoter Group 2.5359572E7 4.33
Hdfc Mutual Fund Public Shareholding 2.2148321E7 3.78
Icici Prudential Mutual Fund Public Shareholding 2.1110103E7 3.6
Kirthi Reddy Kambam Shareholding of Promoter and Promoter Group 2.045E7 3.49
Life Insurance Corporation Of India Public Shareholding 1.9809243E7 3.38
Venkata Ramprasad Reddy Penaka Shareholding of Promoter and Promoter Group 1.8E7 3.07
Axis Clinicals Limited, Trident Chemphar Limited, Rpr Sons Advisors Pvt.ltd. (jointly Holding) Shareholding of Promoter and Promoter Group 1.6726716E7 2.85
Mirae Asset Large Cap Fund Public Shareholding 1.6666465E7 2.84
Quant Mutual Fund Public Shareholding 1.4907336E7 2.54
M Sivakumaran Shareholding of Promoter and Promoter Group 1.449136E7 2.47
Kambam Spoorthi Shareholding of Promoter and Promoter Group 7000000.0 1.19
Rajeshwari Kambam Shareholding of Promoter and Promoter Group 1825500.0 0.31
M Sumanth Kumar Reddy Shareholding of Promoter and Promoter Group 1600000.0 0.27
Trident Chemphar Limited Shareholding of Promoter and Promoter Group 789537.0 0.13
Axis Clinicals Limited Shareholding of Promoter and Promoter Group 658000.0 0.11
Prasada Reddy Kambham Shareholding of Promoter and Promoter Group 301156.0 0.05
Suneela Rani Penaka Shareholding of Promoter and Promoter Group 130000.0 0.02
Penaka Neha Reddy Shareholding of Promoter and Promoter Group 0.0 0.0
K Suryaprakash Reddy Shareholding of Promoter and Promoter Group 7380.0 0.0

AUROBINDO PHARMA LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-20 1.5 Interim 2 2024-02-20 Equity shares 2023-11-20 3.0 Interim 1 2023-11-20 Equity shares 2023-02-17 3.0 Interim 1 2023-02-17 Equity shares 2022-06-06 4.5 Interim 4 2022-06-07 Equity shares 2022-02-18 1.5 Interim 3 2022-02-21 Equity shares 2021-11-17 1.5 Interim 2 2021-11-18 Equity shares 2021-08-27 1.5 Interim 2021-08-30 Equity shares 2021-02-22 1.5 Interim 3 2021-02-23 Equity shares 2020-11-23 1.25 Interim 2 2020-11-24 Equity shares 2020-08-21 1.25 Interim 2020-08-25 Equity shares 2020-02-17 1.75 Interim 2 2020-02-18 Equity shares 2019-11-21 1.25 Interim 2019-11-23 Equity shares 2019-02-15 1.25 Interim 2 2019-02-19 Equity shares 2018-11-20 1.25 Interim 2 2018-11-22 Equity shares 2018-02-20 1.0 Interim 2 2018-02-21 Equity shares 2017-11-21 1.5 Interim 2017-11-22 Equity shares 2017-06-08 1.25 Interim 2 2017-06-09 Equity shares 2016-11-24 1.25 Interim 2016-11-25 Equity shares 2016-06-09 0.7 Interim 4 2016-06-10 Equity shares 2016-02-18 0.7 Interim 3 2016-02-22 Equity shares 2015-11-19 0.6 Interim 2 2015-11-20 Equity shares 2015-08-21 0.5 Interim 2015-08-25 Equity shares 2015-06-08 1.0 Interim 3 2015-06-09 Equity shares 2015-02-16 2.0 Interim 2 2015-02-18 Equity shares 2014-08-13 1.5 Interim 2014-08-19 Equity shares 2014-06-11 1.75 Interim 2 2014-06-12 Equity shares 2013-11-19 1.25 Interim 2013-11-20 Equity shares 2013-07-30 0.5 Final 2013-08-01 Equity shares 2013-02-18 1.0 Interim 2013-02-20 Equity shares 2012-07-30 1.0 Final 2012-08-01 Equity shares 2011-07-20 1.0 Final 2011-07-22 Equity shares 2010-11-11 5.0 Interim 2010-11-12 Equity shares 2010-09-13 2.0 Final 2010-09-15 Equity shares 2010-02-05 3.0 Interim 2010-02-08 Equity shares 2009-12-16 1.5 Final 2009-12-18 Equity shares 2009-02-05 3.0 Interim 2009-02-06 Equity shares 2008-08-11 3.25 Final 2008-08-13 Equity shares 2007-09-14 2.5 Final 2007-09-18 Equity shares 2005-09-20 0.0 Final 2005-09-22 Equity shares
Ex-Date Ex-Bonus Ratio
2015-07-21 2015-07-20 1:1 2000-04-01 2000-03-15 1:1 2000-04-01 2000-03-06 1:1 1998-11-19 1998-10-26 1:1
Ex-Date Old FV NEW FV Record Date
2011-02-10 5.0 1.0 2011-02-11 2003-10-23 10.0 5.0 2003-10-31

Learn More About Stocks

About AUROBINDO PHARMA LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by AUROBINDO PHARMA LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Aurobindo Pharma Ltd?

Answer Field

The share price of Aurobindo Pharma Ltd for NSE is ₹ 1202.4 and for BSE is ₹ 1203.45.

What is the Market Cap of Aurobindo Pharma Ltd?

Answer Field

The market cap of Aurobindo Pharma Ltd for NSE is ₹ 70,453.27 Cr. and for BSE is ₹ 70,514.78 Cr. as of now.

What is the 52 Week High and Low of Aurobindo Pharma Ltd?

Answer Field

The 52 Week High and Low of Aurobindo Pharma Ltd for NSE is ₹ 1212.00 and ₹ 581.25 and for BSE is ₹ 1211.65 and ₹ 581.50.

How to Buy Aurobindo Pharma Ltd share?

Answer Field

You can trade in Aurobindo Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Aurobindo Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 88.03%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader